Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

COMMENTED

Type 1 Diabetes

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

N Engl J Med.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW, iDCL Trial Research Group.

doi: 10.1056/NEJMoa1907863.

Glycemic Control

Overnight Closed Loop Control Improves Glycemic Control in a Multicenter Study of Adults with Type 1 Diabetes

J Clin Endocrinol Metab.

Brown SA, Breton MD, Anderson SM, Kollar L, Keith-Hynes P, Levy CJ, Lam DW, Levister C, Baysal N, Kudva YC, Basu A, Dadlani V, Hinshaw L, McCrady-Spitzer S, Bruttomesso D, Visentin R, Galasso S, Favero SD, Leal Y, Boscari F, Avogaro A, Cobelli C, Kovatchev BP

doi: 10.1210/jc.2017-00556.

RECOMMENDED

Type 1 DiabetesGlycemic Control

Efficacy of Diabeloop closed-loop to improve glycaemic control in patients with type 1 diabetes exposed to copious dinners or to sustained physical exercise

★ 1 Recommended by Prof. emer. Dr Ulrich Keller, Faculty Member

Diabetes Obes Metab.

Hanaire H, Franc S, Borot S, Penfornis A, Benhamou PY, Schaepelynck P, Renard E, Guerci B, Jeandidier N, Simon C, Hannaert P, Xhaard I, Doron M, Huneker E, Charpentier G, Reznik Y

doi: 10.1111/dom.13898.

Type 1 DiabetesGlycemic Control

Lower Daily Carbohydrate Intake Is Associated With Improved Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid Closed-Loop System

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Diabetes Care

Lehmann V, Zueger T, Zeder A, Scott S, Bally L, Laimer M, Stettler C

doi: 10.2337/dc20-1560

COMMENTED

Type 1 Diabetes

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

Lancet.

Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam Consortium

doi: 10.1016/S0140-6736(18)31947-0.

Diabetes - GeneralType 1 DiabetesGlycemic Control

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm

Diabetes Technol Ther.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT

doi: 10.1089/dia.2017.0346.

Glycemic Control

Advanced Closed-Loop Control System Improves Postprandial Glycemic Control Compared With a Hybrid Closed-Loop System Following Unannounced Meal

Diabetes Care

Garcia-Tirado J, Diaz JL, Esquivel-Zuniga R, Koravi CLK, Corbett JP, Dawson M, Wakeman C, Barnett CL, Oliveri MC, Myers H, Krauthause K, Breton MD, DeBoer MD

doi: 10.2337/dc21-0932

COMMENTED

Type 1 DiabetesGlycemic Control

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Diabetes Care.

Dandona P, Mathieu C, Phillip M, Hansen L, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators

doi: 10.2337/dc18-1087.

Diabetes - GeneralType 1 DiabetesGlycemic Control

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes

Diabetes Technol Ther.

Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW

doi: 10.1089/

Related content

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

Overnight Closed Loop Control Improves Glycemic Control in a Multicenter Study of Adults with Type 1 Diabetes

Efficacy of Diabeloop closed-loop to improve glycaemic control in patients with type 1 diabetes exposed to copious dinners or to sustained physical exercise

Lower Daily Carbohydrate Intake Is Associated With Improved Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid Closed-Loop System

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm

Advanced Closed-Loop Control System Improves Postprandial Glycemic Control Compared With a Hybrid Closed-Loop System Following Unannounced Meal

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes